Fanqiang Meng

Sun Yat-sen University, Beijing Friendship Hospital

Papers

2

Total Citations

25

H-Index

2

About

Fanqiang Meng is a pioneering researcher at the intersection of bioengineering, oncology, and advanced robotics. His work focuses on developing innovative therapeutic platforms that harness living materials and precision surgical technologies to overcome critical barriers in cancer treatment. Meng’s most notable contribution is the creation of photosynthetic algae-based microrobots that act as living materials to combat tumor hypoxia. By engineering these microalgae to generate oxygen within the tumor microenvironment, his team has demonstrated a groundbreaking method to enhance T cell infiltration and anti-tumor immunity, directly addressing a major limitation of current immunotherapies. This highly cited work (23 citations in 2024) positions him as a leader in the emerging field of biohybrid microrobotics for cancer therapy. Additionally, Meng has made significant strides in clinical precision, leading a comparative study on multimodal image-guided surgical robots versus 3D-printed templates for brachytherapy of malignant tumors in complex anatomical regions like the skull base. His research not only advances fundamental understanding of immune modulation but also translates directly into improved surgical outcomes, showcasing a rare blend of basic science innovation and clinical application.

Research Focus

Key Achievements

2
H-Index
2
Papers
25
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Engineered algae microrobots as photosynthetic living materials promote T cells’ anti-tumor immunity
23 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Sun Yat-sen University, Beijing Friendship Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago